8A41.1ICD-11 MMS 2026-01
Neuromyelitis optica myelin oligodendrocyte glycoprotein antibody-positive
Description
MOG antibody associated spectrum disorders are inflammatory demyelinating diseases of the central nervous system with a predilection for optic nerve that include a subgroup of patients with bilateral optic neuritis (ON), longitudinally extensive (> 3 vertebral segments) myelitis (often recurrent) and rarely patients with an NMO like presentation. The clinical and immunopathological phenotype is under active investigation
Index terms
- Neuromyelitis optica myelin oligodendrocyte glycoprotein antibody-positive
- MOG antibody-positive neuromyelitis optica
Exclusions from above levels
05– Endocrine, nutritional or metabolic diseases18– Complications of pregnancy, childbirth and the puerperium19– Certain conditions originating in the perinatal period
Show allHide
22– Injury, poisoning or certain other consequences of external causes
Sibling codes
Foundation entity
Neuromyelitis optica myelin oligodendrocyte glycoprotein antibody-positive – http://id.who.int/icd/entity/605048789
Part of: 8A41: Isolated demyelinating syndromes of the central nervous system › 08: Diseases of the nervous system